NCT03721744 2024-04-03A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer1Globe Biomedical Co., Ltd.Phase 2/3 Recruiting336 enrolled